GBT021601

· Pfizer

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for GBT021601, covering 2024-10-15 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: GBT021601-022: A Study of GBT021601 in Participants With Sickle Cell Disease (SCD) [Phase 2, Phase 3]